Provided By Business Wire
Last update: Apr 18, 2025
Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.
The release was issued in error by Aditxt, Inc..
A replacement release will not be issued at this time.